spacer
home > pmps > autumn 2018 > postponement potential
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Postponement Potential

Postponement packaging, or late-stage customisation, is the supply chain practice of keeping a product in a standard format for as long as possible, only making it market- or customer-specific when demand arises. To date, the adoption of postponement across the pharmaceutical supply chain has been limited. However, given the potential cost, resource, and time savings associated with postponement, companies can benefit from the significant advantages this strategy has to offer.

Postponement Principle

The fundamental principle of postponement is to keep products market-agnostic to enable drug manufacturers to react quickly to changes in demand. It offers businesses a strategic solution to respond to specific market needs, optimising their inventory management and simplifying their supply chain.

Rather than finalising a product and moving it to the relevant country for storage, it can be partially prepared and then stored in a centrally located warehouse. Then, when stock is needed, it can be tailored according to marketspecific requirements and shipped within very short timeframes – sometimes, in a matter of hours.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dexter Tjoa is the Director of Corporate Strategy at Tjoapack. He is responsible for devising, implementing, and evaluating the midto long-term strategies of the company and the services it offers, as well as overseeing the commercial department within Tjoapack. Dexter holds a BSc in mathematics from the University of London, UK, and an MSc in mathematics and computer science from the University of Oxford, UK, and has previously worked in the technology sector.
spacer
Dexter Tjoa
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

HemaCare and Tissue Solutions Announce Strategic Partnership to Expand Access to Human Disease-State Samples

HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development, and Tissue Solutions Ltd, a leading global provider of diseased human biosamples for research, today announced their partnership to supply customers with an expanded selection of well-qualified disease-state biomaterials in fresh, frozen, and FFPE formats.
More info >>

White Papers

Securing the Global Pharmaceutical Supply Chain against the Threat of Counterfeit Drugs

World Courier

With a fully integrated GxP-compliant transport, storage and distribution system in place and over 140 wholly owned ISO 9001 - certified offices in more than 50 countries, WORLD COURIER, an AmerisourceBergen® company, is the world’s largest and most experienced provider of specialty courier services. It is uniquely positioned to meet the most demanding industry requirements for managing the global distribution of time - and temperaturesensitive pharmaceutical products and IMPs used commercially or in clinical trials.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement